Literature DB >> 3753464

Concentration and relative molecular mass of hyaluronate in lymph and blood.

A Tengblad, U B Laurent, K Lilja, R N Cahill, A Engström-Laurent, J R Fraser, H E Hansson, T C Laurent.   

Abstract

Human lymph was collected from patients with leaking lymph vessels after thoracic surgery. Ovine lymph was obtained from the mesenteric, lumbar, popliteal and prescapular lymph ducts by cannulation. The concentration of hyaluronate varied considerably (between 0.2 and 50 mg/l) and the highest concentrations were found in mesenteric lymph. The Mr of the polysaccharide showed a great polydispersity and variation between individuals and in different regions of the lymphatic system. High-Mr hyaluronate (greater than 10(6) was present in lymph both from man and sheep. Hyaluronate was also isolated by affinity chromatography in 70-80% yield from human serum and plasma obtained from healthy individuals and patients with rheumatoid arthritis and primary biliary cirrhosis. The weight (Mw)- and number (Mn)-average relative molecular masses were roughly the same in the three groups [(1.4-2.7) X 10(5) and (2.1-5.7) X 10(4) respectively]. The low Mr of hyaluronate in blood compared with that in lymph is explained by a preferential uptake of the large molecules by the liver endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753464      PMCID: PMC1146871          DOI: 10.1042/bj2360521

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Binding of hyaluronate and chondroitin sulphate to liver endothelial cells.

Authors:  T C Laurent; J R Fraser; H Pertoft; B Smedsrød
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

3.  Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver.

Authors:  S Eriksson; J R Fraser; T C Laurent; H Pertoft; B Smedsrød
Journal:  Exp Cell Res       Date:  1983-03       Impact factor: 3.905

4.  Quantitative analysis of hyaluronate in nanogram amounts.

Authors:  A Tengblad
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

5.  Determination of hyaluronate in biological samples by a specific radioassay technique.

Authors:  U B Laurent; A Tengblad
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

6.  [A method for the long-term collection of efferent lymph from the superficial cervical node in sheep].

Authors:  H H Heitmann
Journal:  Zentralbl Veterinarmed A       Date:  1970-06

7.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

8.  Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage.

Authors:  A Tengblad
Journal:  Biochim Biophys Acta       Date:  1979-06-19

9.  The molecular weight of hyaluronate in the aqueous humour and vitreous body of rabbit and cattle eyes.

Authors:  U B Laurent; K A Granath
Journal:  Exp Eye Res       Date:  1983-04       Impact factor: 3.467

10.  Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit.

Authors:  J R Fraser; T C Laurent; H Pertoft; E Baxter
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

View more
  26 in total

1.  A pharmacokinetic model of intravenously administered hyaluronan in sheep.

Authors:  L Lebel; J R Fraser; W S Kimpton; J Gabrielsson; B Gerdin; T C Laurent
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

2.  Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Authors:  Nadine Nagy; Vivekananda G Sunkari; Gernot Kaber; Sonia Hasbun; Dung N Lam; Cate Speake; Srinath Sanda; Tracey L McLaughlin; Thomas N Wight; Steven R Long; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-09-06       Impact factor: 11.583

3.  Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin.

Authors:  S Gustafson; T Björkman
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Nomenclature of hyaluronic acid.

Authors:  S K Singla
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

5.  Uptake and degradation of hyaluronan in lymphatic tissue.

Authors:  J R Fraser; W G Kimpton; T C Laurent; R N Cahill; N Vakakis
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

6.  Agarose and polyacrylamide gel electrophoresis methods for molecular mass analysis of 5- to 500-kDa hyaluronan.

Authors:  Shardul Bhilocha; Ripal Amin; Monika Pandya; Han Yuan; Mihir Tank; Jaclyn LoBello; Anastasia Shytuhina; Wenlan Wang; Hans-Georg Wisniewski; Carol de la Motte; Mary K Cowman
Journal:  Anal Biochem       Date:  2011-05-27       Impact factor: 3.365

7.  The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.

Authors:  Madhu S Pandey; Bruce A Baggenstoss; Jennifer Washburn; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

8.  Filtration rate dependence of hyaluronan reflection by joint-to-lymph barrier: evidence for concentration polarisation.

Authors:  S Sabaratnam; R M Mason; J R Levick
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

9.  Elimination of stabilised hyaluronan from the knee joint in healthy men.

Authors:  Ulla Lindqvist; Vladimir Tolmachev; Kalevi Kairemo; Gunnar Aström; Eva Jonsson; Hans Lundqvist
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Molecular mass dependence of hyaluronan detection by sandwich ELISA-like assay and membrane blotting using biotinylated hyaluronan binding protein.

Authors:  Han Yuan; Mihir Tank; Abeer Alsofyani; Naman Shah; Nishant Talati; Jaclyn C LoBello; Jin Ryoun Kim; Yoji Oonuki; Carol A de la Motte; Mary K Cowman
Journal:  Glycobiology       Date:  2013-08-19       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.